This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
- Investigator
- Jeb M Justice
- Status
- Accepting Candidates
- Ages
- 18 Years - N/A
- Sexes
- All
Update your location to show providers, locations, and services closest to you.
Ear, Nose and Throat Specialist (Otolaryngologist)
This study will evaluate the efficacy and safety of depemokimab (GSK3511294) in participants with CRSwNP.
The primary objectives of the study are: To longitudinally characterize the long-term effectiveness of DUPIXENT® through assessment of patient-reported symptoms, Health-Related Quality of Life (HRQoL) related to Chronic rhinosinusitis with nasal…
33 publications
2021
Chemical senses
PubMed • Publisher's site2021
Chemical senses
PubMed • Publisher's site2021
ORL; journal for oto-rhino-laryngology and its related specialties
PubMed • Publisher's site2020
Chemical senses
PubMed • Publisher's site2020
medRxiv : the preprint server for health sciences
PubMed • Publisher's site